Download FREE Report Sample
Download Free sampleSkin-related issues are one of the frequently occurring issues worldwide. One such issue is Sporotrichosis. Sporotrichosis is caused by a dimorphic fungus, called Sporothrix Schenckii, and is commonly called gardeners' disease due to number of people affected when carrying out cultivation in farms and gardens. The fungus is abundantly found in soil and on plant matter such as sphagnum moss and rose bushes, which makes it a valid reason for affecting people associated with gardening and cultivation. Fungal spores present in the environment are a major cause of Infection and usually affect cutaneous and subcutaneous tissues. Humans coming in contact with the spores that are present in the soil undergo this type of infection. Cutaneous (skin) infection is a commonly occurring form of this infection. It occurs when the fungus enters the skin through a small cut or scrape, especially when someone comes in contact with contaminated plant matter. Medicines employed majorly for the treatment of sporotrichosis include itraconazole and amphotericin B. Fluconazole and ketoconazole are used; however, they are utilized conditions when itraconazole therapy does not work.
Sporothrix Schenckii Infection Treatment Market contains market size and forecasts of Sporothrix Schenckii Infection Treatment in Global, including the following market information:
Global Sporothrix Schenckii Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sporothrix Schenckii Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Itraconazole Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sporothrix Schenckii Infection Treatment include Elanco., Sentosa Geigy, Mylan Pharmaceuticals Inc, Accord-UK Ltd, Avimedical B.V and Success Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sporothrix Schenckii Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sporothrix Schenckii Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sporothrix Schenckii Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Saturated Solution of Potassium Iodide (SSKI)
Global Sporothrix Schenckii Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sporothrix Schenckii Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Global Sporothrix Schenckii Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sporothrix Schenckii Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
